光学相干断层扫描血管成像自动量化糖尿病患者三个血管丛的无灌注区
这项横断面研究在三级学术中心纳入健康对照和不同严重程度糖尿病视网膜病变患者,使用投影分辨OCTA量化黄斑三个血管丛的毛细血管无灌注。研究发现,三层分割方案自动量化的无灌注区在区分视网膜病变严重程度时,灵敏度高于未分割内层视网膜或商业血管密度测量,但需进一步研究其临床适用性。
要点
- 三层分割EAA总和检测重度DR的灵敏度为97%,高于内层视网膜EAA的47%。
- 三层分割EAA总和检测糖尿病患者的灵敏度为69%,高于内层视网膜EAA的28%。
- 无灌注区与信号强度指数无关,而商业血管密度依赖SSI且灵敏度较低。
核心结论
- 使用PR-OCTA的三层分割方案自动量化无灌注区,区分视网膜病变水平的灵敏度高于未分割内层视网膜或商业两层方案血管密度测量。
研究设计与样本
- 横断面研究,纳入健康对照39人、无视网膜病变糖尿病患者16人、轻中度非增殖性DR患者23人、重度非增殖性DR或增殖性DR患者32人,每人均取1眼。
主要发现
- 黄斑中心凹无血管区面积均值:对照组0.203 mm2,无DR组0.192 mm2,轻中度NPDR组0.243 mm2,重度NPDR/PDR组0.359 mm2。
- 全内层视网膜EAA均值:对照组0.020 mm2,无DR组0.034 mm2,轻中度NPDR组0.038 mm2,重度NPDR/PDR组0.237 mm2。
- 三层分割EAA总和均值:对照组0.103 mm2,无DR组0.213 mm2,轻中度NPDR组0.451 mm2,重度NPDR/PDR组1.325 mm2。
- 特异性固定95%时,内层视网膜EAA检测糖尿病患者灵敏度28%(95%CI 18%-40%),检测DR患者31%(95%CI 19%-45%),检测重度DR患者47%(95%CI 29%-65%)。
- 三层分割EAA总和对应灵敏度分别为69%(95%CI 57%-80%)、82%(95%CI 70%-91%)、97%(95%CI 85%-100%)。
关键数值与推荐
- 无灌注区与信号强度指数无关联;商业两层方案血管密度区分组间灵敏度较低且依赖SSI。
临床怎么用
- PR-OCTA三层分割自动量化无灌注区可能为评估DR提供客观定量方法,但原文指出需进一步研究其在临床环境中的适用性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Diabetic retinopathy (DR) is a leading cause of vision loss that is managed primarily through qualitative clinical examination of the retina. Optical coherence tomography angiography (OCTA) may offer an objective and quantitative method of evaluating DR. OBJECTIVE: To quantify capillary nonperfusion in 3 vascular plexuses in the macula of eyes patients with diabetes of various retinopathy severity using projection-resolved OCTA (PR-OCTA). DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study at a tertiary academic center comprising 1 eye each from healthy control individuals and patients with diabetes at different severity stages of retinopathy. Data were acquired and analyzed between January 2015 and December 2017. MAIN OUTCOMES AND MEASURES: Foveal avascular zone area, extrafoveal avascular area (EAA), and the sensitivity of detecting levels of retinopathy. RESULTS: The study included 39 control individuals (20 women [51%]; mean [SD] age, 43.41 [19.37] years); 16 patients with diabetes without retinopathy (8 women [50%]; mean [SD] age, 56.50 [12.43] years); 23 patients with mild to moderate nonproliferative DR (18 women [78%] ; mean [SD] age, 62.48 [10.55] years); and 32 patients with severe nonproliferative DR or proliferative DR (12 women [38%]; mean age, 53.41 [14.05] years). Mean (SD) foveal avascular zone area was 0.203 (0.103) mm2 for control individuals, 0.192 (0.084) mm2 for patients with diabetes without retinopathy, 0.243 [0.079] mm2 for mild to moderate nonproliferative DR, and 0.359 (0.275) mm2 for severe nonproliferative DR or proliferative DR. Mean (SD) EAA in whole inner retinal slab in these groups, respectively, were 0.020 (0.031) mm2, 0.034 (0.047) mm2, 0.038 (0.040) mm2, and 0.237 (0.235) mm2. The mean (SD) sum of EAA from 3 segmented plexuses in each of the respective groups were 0.103 (0.169) mm2, 0.213 (0.242) mm2, 0.451 (0.243) mm2, and 1.325 (1.140) mm2. With specificity fixed at 95%, using EAA in inner retinal slab, the sensitivity of detecting patients with diabetes from healthy control individuals was 28% (95% CI, 18%-40%), 31% for patients with DR (95% CI, 19%-45%), and 47% for patients with severe DR (95% CI, 29%-65%) from whole inner retinal EAA. With the sum of EAA from 3 individual plexuses, the sensitivities were 69% (95% CI, 57%-80%), 82% (95% CI, 70%-91%), and 97% (95% CI, 85%-100%), respectively. Avascular areas were not associated with signal strength index. The commercial vessel density from the 2-plexus scheme distinguished the groups with lower sensitivity and were dependent on SSI. CONCLUSIONS AND RELEVANCE: Automatically quantified avascular areas from a 3-layer segmentation scheme using PR-OCTA distinguished levels of retinopathy with a greater sensitivity than avascular areas from unsegmented inner retinal slab or measurements from a commercially available vessel density in 2-layer scheme. Additional studies are needed to investigate the applicability of nonperfusion parameters in clinical settings.
引用
- Hwang TS, Hagag AM, Wang J, et al. Automated Quantification of Nonperfusion Areas in 3 Vascular Plexuses With Optical Coherence Tomography Angiography in Eyes of Patients With Diabetes. JAMA Ophthalmol. 2018. PMID: 29902297. doi:10.1001/jamaophthalmol.2018.2257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。